Article

A new 21-Gene Expression Assay Recurrence Score in Estrogen Receptor-Positive and Lymph Node-Negative Early-Stage Breast Cancer Patients

2023-09-11

Abstract excerpt

This aimed to validate 21 Oncotype DX gene in a retrospective trial involving women with hormone receptor-positive, human epidermal growth factor receptor type 2 (HER2)–negative, axillary node-negative breast cancer with tumors measuring 1.1 to 5.0 cm in their largest dimension. The ROC curve for each gene, showed the sensitivity of BAG1 and KI67 ranged between 96.08 and 99.46 percent. Survivin and BAG1 had gene s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8a8284c9-60c4-55d3-aa76-b0115aea4a76
DOI: 10.21203/rs.3.rs-3239135/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A new 21-Gene Expression Assay Recurrence Score in Estrogen Receptor-Positive and Lymph Node-Negative Early-Stage Breast Cancer PatientsDOI 10.21203/rs.3.rs-3239135/v1Read

Prospective Validation of a 21-Gene Expression Assay in Breast CancerSemantic proximity Read

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerSemantic proximity Read

Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis.Semantic proximity Read

The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in KoreaSemantic proximity Read

PreciseBreast is prognostic for breast cancer recurrence in a 21-gene assay managed cohortSemantic proximity Read

21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010-2013.Semantic proximity Read

Utilization and Outcomes of the 21-Gene Recurrence Score in pN2 Breast Cancer PatientsSemantic proximity Read

Impact of Different Modules of 21-Gene Assay in Early Breast Cancer PatientsSemantic proximity Read

Favorable Locoregional Control in Clinically Node- Negative Hormone-receptor Positive Breast Cancer With Low 21-gene Recurrence Scores: a Single Institutional Study With 10-year Follow-upSemantic proximity Read

BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization.Semantic proximity Read

Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer.Semantic proximity Read

Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.Semantic proximity Read